2012•Molecular Genetics and MetabolismRequires access

Intra-articular Enzyme Replacement Therapy with Recombinant Human Iduronidase is Safe and Well Tolerated in the Canine Model of Mucopolysaccharidosis Type I

Raymond Wang, Afshin Aminian, Shih-shin Kan, Steven Q. Le, Catalina Guerra, Patricia Dickson

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Enzyme replacement therapy, Mucopolysaccharidosis I, Lysosomal storage disease, Mucopolysaccharidosis type I, Mucopolysaccharidosis, Hurler syndrome, Medicine, Meninges

Back to paper search Browse research topics Original source

Intra-articular Enzyme Replacement Therapy with Recombinant Human Iduronidase is Safe and Well Tolerated in the Canine Model of Mucopolysaccharidosis Type I — Research Paper | ScholarLens